Severe Asthma ToolkitSevere Asthma Toolkit
HomeAboutSpecific PopulationsRegistriesContributorsContact
Twitter
  • What is Severe Asthma?
    • Overview
    • Definition
    • Prevalence & Burden
    • Pathophysiology
    • Symptoms
    • Severe Asthma Attacks / Exacerbations / Flare-ups
    • Asthma Phenotypes
  • Diagnosis & Assessment
    • Overview
    • Diagnosis Overview
    • Assessment Overview
    • Lung Function Assessments
    • Questionnaires
    • Allergy Assessments
    • Phenotyping
    • Bronchoscopy
    • Imaging
    • Occupational Asthma
  • Management
    • Overview
    • Asthma Education
      • About Severe Asthma
      • Asthma Pathophysiology
      • Medications Education
      • Self-Monitoring
      • Triggers
      • Review
    • Written Action Plans
    • Adherence
    • Inhaler Technique
    • Physical Activity & Exercise
    • Interdisciplinary Approach & Multidimensional Assessment
    • Referral
  • Medications
    • Overview
    • Relievers
    • Preventers / Controllers
    • Add-on Therapies
    • Monoclonal Antibodies
    • Bronchial Thermoplasty
  • Co-Morbidities
    • Overview
    • Pulmonary & Upper Airways
      • Allergic & Non-Allergic Rhinitis
      • Chronic Rhinosinusitis
      • Dysfunctional Breathing
      • Vocal Cord Dysfunction
      • Chronic Obstructive Pulmonary Disease
      • Bronchiectasis
      • Obstructive Sleep Apnoea
    • Extra-Pulmonary
      • Obesity
      • Anxiety & Depression
      • Gastro-oesophageal Reflux Disease (GORD)
      • Osteoporosis
      • Cardiovascular Disease & Metabolic Disease
  • Living with Severe Asthma
    • Overview
    • Daily Symptom Burden
    • Mental & Emotional Health
    • Intimacy & Relationships
    • Self-Management Support
    • Medication Use & Costs
    • Experience of Care
    • Experience of Asthma Attacks
    • Prognosis
  • Establishing a Clinic
    • Overview
    • Set-up
    • Staffing & Multidisciplinary Team Approach
    • Facilities
    • Delivery Approach
    • Tailored Referrals
    • Evaluation
    • Opportunities for Training & Research
    • Barriers & Hurdles
  • Paediatrics
    • Overview
    • Management in Paediatrics
    • Assessment in Paediatrics
    • Alternative Diagnosis & Co-Morbidities in Paediatrics
    • Psychosocial Issues in Paediatrics
    • Medications in Paediatrics
    • Asthma in the Adolescent Population
  • Resources
    • Overview
    • Clinic Recommendations
    • Infographics
    • Asthma Assessment Resources
    • Systematic & Multidimensional Assessment Resources
      • Airway Components
      • Comorbidity Components
      • Risk Factor Components
    • Translation & Implementation
    • Case Studies
    • Presentations
    • Videos
    • Relevant Links
    • Key References

Medication Use & Costs

Home Living with Severe Asthma Medication Use & Costs

People with severe asthma continue to experience symptoms and disease burden, despite taking medications. Medication costs are ongoing and can be high. Significant side effects can also result, in particular from ongoing high-dose oral corticosteroids. These factors can contribute to doubts about treatment efficacy and reduce adherence and compliance to prescribed medications or promote overuse of reliever medications. Decreased medication use, without medical recommendation, puts people at increased risk of severe asthma attacks / exacerbations.

“I hate it, I never liked taking tablets or medicine and now I depend on them…a lot of times I miss taking my medication at night….at the start of the day I can’t be bothered, but I know if I don’t, I’m in trouble”
Video provided by Associate Professor Lorraine Smith and Ms. Daniela Eassey, University of Sydney.

“I felt uncomfortable, I was despairing….I lost faith”
Video provided by Associate Professor Lorraine Smith and Ms. Daniela Eassey, University of Sydney.

People with severe asthma will weigh the benefits of taking medications (e.g. oral corticosteroids), against the impact of side effects. It is important to recognise that what may appear as ‘non-compliance’ is often a conscious/strategic choice adopted by a patient. Exploring patients’ experiences in a non-judgemental and open way will help to uncover the true reasons for this apparent non-compliance, enabling the healthcare provider to work with their patient to find solutions that will work for the patient. For more information see Adherence

In addition to medication costs, people with severe asthma experience additional financial costs. These include:

  • Long-term medication costs
  • Cost to treat/manage medication side-effects
  • Absence from work – due to disease burden or clinic appointments/travel
  • Associated travel costs, to attend appointments

“I just got to keep working and do overtime….to pay for the medication….it ranges anywhere from $100-150 per week….it all starts adding up really quick”
Video provided by Associate Professor Lorraine Smith and Ms. Daniela Eassey, University of Sydney.

“Private health covers it to a point….I have puffers that cost $100 each….I’m supposed to be on nasal spray all the time, but I try not to”
Video provided by Associate Professor Lorraine Smith and Ms. Daniela Eassey, University of Sydney.

Asthma Australia and the National Asthma Council have patient-facing websites that offer support for effectively managing the burdens of medication use and costs.

Previous
Next

Last Updated on February 12, 2019

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

More results...

  • Overview
  • Daily Symptom Burden
  • Mental & Emotional Health
  • Intimacy & Relationships
  • Self-Management Support
  • Medication Use & Costs
  • Experience of Care
  • Experience of Asthma Attacks
  • Prognosis

We want to know who accesses the Severe Asthma Toolkit and how it is used. Please complete our survey.

Responses will inform the continued development of the Severe Asthma Toolkit and future translation and implementation activities. Any feedback you provide will be greatly appreciated.

Complete Survey

  • Website Terms of Use
  • Website Survey
© Copyright 2018    CRICOS Provider Number 00109J    The University of Newcastle, Australia